Compare Celecoxib and Ibuprofen Sr In The Management Of Acute Pain Post Orthopedic Or Gynecological Surgery
Status:
Completed
Trial end date:
2005-07-01
Target enrollment:
Participant gender:
Summary
To validate the analgesic efficacy and safety of celecoxib compared with ibuprofen SR in the
management of acute pain post orthopedic or gynecological surgery
Phase:
Phase 3
Details
Lead Sponsor:
Pfizer Pfizer's Upjohn has merged with Mylan to form Viatris Inc.